Catalent Pharma Solutions, Inc. (CTLT)
Dec 18, 2024 - CTLT was delisted (reason: acquired by Novo Holdings)
63.48
0.00 (0.00%)
Inactive · Last trade price on Dec 17, 2024

Catalent Statistics

Total Valuation

Market Cap n/a
Enterprise Value n/a

Important Dates

The last earnings date was Friday, February 7, 2025, before market open.

Earnings Date Feb 7, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 181.51M
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) -0.55%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 2.39
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.52

Current Ratio 1.52
Quick Ratio 0.97
Debt / Equity n/a
Debt / EBITDA 7.05
Debt / FCF 56.16
Interest Coverage 1.43

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) 4.84%
Return on Invested Capital (ROIC) 6.49%
Return on Capital Employed (ROCE) 8.85%
Revenue Per Employee $218,470
Profits Per Employee $988
Employee Count 17,800
Asset Turnover 0.59
Inventory Turnover 7.64

Taxes

In the past 12 months, Catalent has paid $66.00 million in taxes.

Income Tax 66.00M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +53.04% in the last 52 weeks. The beta is 1.16, so Catalent's price volatility has been higher than the market average.

Beta (5Y) 1.16
52-Week Price Change +53.04%
50-Day Moving Average 60.46
200-Day Moving Average 58.23
Relative Strength Index (RSI) 74.48
Average Volume (20 Days) 3,288,091

Short Selling Information

The latest short interest is 14.74 million, so 8.12% of the outstanding shares have been sold short.

Short Interest 14.74M
Short Previous Month 8.44M
Short % of Shares Out 8.12%
Short % of Float 8.17%
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Catalent had revenue of $1.81 billion and earned $8.20 million in profits.

Revenue 1.81B
Gross Profit 582.00M
Operating Income 236.90M
Pretax Income 45.40M
Net Income 8.20M
EBITDA 383.10M
EBIT 236.90M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

The company has $55.70 million in cash and $2.70 billion in debt, giving a net cash position of -$2.65 billion.

Cash & Cash Equivalents 55.70M
Total Debt 2.70B
Net Cash -2.65B
Net Cash Per Share n/a
Equity (Book Value) -395.90M
Book Value Per Share n/a
Working Capital 214.10M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $147.80 million and capital expenditures -$99.70 million, giving a free cash flow of $48.10 million.

Operating Cash Flow 147.80M
Capital Expenditures -99.70M
Free Cash Flow 48.10M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 32.10%, with operating and profit margins of 13.06% and 0.45%.

Gross Margin 32.10%
Operating Margin 13.06%
Pretax Margin 2.50%
Profit Margin 0.45%
EBITDA Margin 21.13%
EBIT Margin 13.06%
FCF Margin 2.65%

Dividends & Yields

Catalent does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference -0.13%
Analyst Consensus Hold
Analyst Count 6
Revenue Growth Forecast (5Y) 7.51%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Catalent has an Altman Z-Score of 0.27 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.27
Piotroski F-Score 4